1Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
3Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
4Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference | Sex/Age (yr) | Endoscopic finding | Sites | Invovement | Serum IgG4 | Procedure | Associated condition |
---|---|---|---|---|---|---|---|
Baez et al. [10] | M/58 | Nodule, 1.4 cm | Fundus and body | Mucosa | Normal | Steroid | AIP, IgG4-related sialadenitis |
Kaji et al. [11] | M/74 | Mutiple polyps with erosion and redness | Body | Mucosa | Increased | NA | AIP |
Chetty et al. [12] | F/45 | Nodule, 1.5 cm | Fundus | Submucosa | Normal | WR | Raynaud’s disease |
Chetty et al. [12] | M/60 | Multiple nodules, up to 2.2 cm | Antrum | Proper muscle to submucosa | NA | DG | Autoimmune polyendocrinopathy |
Rollins et al. [13] | F/75 | Polypoid lesion, 5.6 cm | Body | Submucosa | NA | WR | None |
Na et al. [9] | M/56 | Nodule, 0.8 cm | Low body | Submucosa | NA | ESD | Type 2 diabetes mellitus |
Kim et al. [14] | F/59 | Mass, 3.3 cm | Midbody | Proper muscle | Normal | WR | None |
Kim et al. [14] | F/54 | Mass, 2.1 cm | NA | Proper muscle to submucosa | Normal | WR | None |
Present case | F/48 | Mass, 3.6 cm | Midbody | Submucosa to subserosa | NA | WR | None |
Reference | Sex/Age (yr) | Endoscopic finding | Sites | Invovement | Serum IgG4 | Procedure | Associated condition |
---|---|---|---|---|---|---|---|
Baez et al. [10] | M/58 | Nodule, 1.4 cm | Fundus and body | Mucosa | Normal | Steroid | AIP, IgG4-related sialadenitis |
Kaji et al. [11] | M/74 | Mutiple polyps with erosion and redness | Body | Mucosa | Increased | NA | AIP |
Chetty et al. [12] | F/45 | Nodule, 1.5 cm | Fundus | Submucosa | Normal | WR | Raynaud’s disease |
Chetty et al. [12] | M/60 | Multiple nodules, up to 2.2 cm | Antrum | Proper muscle to submucosa | NA | DG | Autoimmune polyendocrinopathy |
Rollins et al. [13] | F/75 | Polypoid lesion, 5.6 cm | Body | Submucosa | NA | WR | None |
Na et al. [9] | M/56 | Nodule, 0.8 cm | Low body | Submucosa | NA | ESD | Type 2 diabetes mellitus |
Kim et al. [14] | F/59 | Mass, 3.3 cm | Midbody | Proper muscle | Normal | WR | None |
Kim et al. [14] | F/54 | Mass, 2.1 cm | NA | Proper muscle to submucosa | Normal | WR | None |
Present case | F/48 | Mass, 3.6 cm | Midbody | Submucosa to subserosa | NA | WR | None |
M, male; AIP, autoimmune pancreatitis; NA, not available; F, female; WR, wedge resection; DG, distal gastrectomy; ESD, endoscopic submucosal dissection.